- Home
- APVO vs MGRX Comparison
APVO vs MGRX Comparison
Compare APVO & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- MGRX
- Stock Information
- Founded
- APVO 2016
- MGRX 2021
- Country
- APVO United States
- MGRX United States
- Employees
- APVO N/A
- MGRX N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- MGRX Computer Software: Prepackaged Software
- Sector
- APVO Health Care
- MGRX Technology
- Exchange
- APVO Nasdaq
- MGRX Nasdaq
- Market Cap
- APVO 5.4M
- MGRX 6.3M
- IPO Year
- APVO N/A
- MGRX 2023
- Fundamental
- Price
- APVO $3.47
- MGRX $4.33
- Analyst Decision
- APVO Strong Buy
- MGRX
- Analyst Count
- APVO 1
- MGRX 0
- Target Price
- APVO $296.00
- MGRX N/A
- AVG Volume (30 Days)
- APVO 44.0K
- MGRX 163.8K
- Earning Date
- APVO 03-04-2025
- MGRX 03-31-2025
- Dividend Yield
- APVO N/A
- MGRX N/A
- EPS Growth
- APVO N/A
- MGRX N/A
- EPS
- APVO N/A
- MGRX N/A
- Revenue
- APVO N/A
- MGRX $755,000.00
- Revenue This Year
- APVO N/A
- MGRX N/A
- Revenue Next Year
- APVO N/A
- MGRX N/A
- P/E Ratio
- APVO N/A
- MGRX N/A
- Revenue Growth
- APVO N/A
- MGRX 52.20
- 52 Week Low
- APVO $3.01
- MGRX $2.07
- 52 Week High
- APVO $399.60
- MGRX $16.80
- Technical
- Relative Strength Index (RSI)
- APVO 33.42
- MGRX 58.08
- Support Level
- APVO $3.20
- MGRX $3.90
- Resistance Level
- APVO $3.65
- MGRX $6.15
- Average True Range (ATR)
- APVO 0.34
- MGRX 0.58
- MACD
- APVO 0.01
- MGRX 0.08
- Stochastic Oscillator
- APVO 31.51
- MGRX 44.76
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.